|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
136,480,000 |
Market
Cap: |
3.68(B) |
Last
Volume: |
503,160 |
Avg
Vol: |
501,793 |
52
Week Range: |
$26.23 - $39.94 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Papa Joseph C |
President and CEOChairman |
|
2011-10-24 |
4 |
OE |
$20.50 |
$205,000 |
D/D |
10,000 |
121,412 |
|
- |
|
Papa Joseph C |
President and CEOChairman |
|
2011-09-22 |
4 |
AS |
$92.35 |
$932,542 |
D/D |
(10,000) |
111,412 |
|
- |
|
Kingma Todd W |
Executive VP, General Counsel |
|
2011-09-01 |
4 |
S |
$94.75 |
$14,592 |
D/D |
(154) |
21,738 |
|
- |
|
Kingma Todd W |
Executive VP, General Counsel |
|
2011-09-01 |
4 |
OE |
$20.50 |
$3,157 |
D/D |
154 |
21,892 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2011-09-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
40,279 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-09-01 |
4 |
AS |
$94.75 |
$94,750 |
D/D |
(1,000) |
3,372 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-08-31 |
4 |
GD |
$0.00 |
$0 |
I/I |
190 |
206,092 |
|
- |
|
Gibbons David T |
Director |
|
2011-08-31 |
4 |
S |
$95.31 |
$2,814,879 |
D/D |
(29,500) |
3,002 |
|
- |
|
Gibbons David T |
Director |
|
2011-08-31 |
4 |
OE |
$18.18 |
$318,150 |
D/D |
17,500 |
47,502 |
|
- |
|
Arkin Moshe |
Director |
|
2011-08-31 |
4 |
S |
$94.55 |
$7,645,863 |
I/I |
(79,855) |
4,983,267 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-08-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
4,372 |
|
- |
|
Needham Jeffrey |
Sr. VP Commercial Business Dev |
|
2011-08-31 |
4 |
S |
$95.55 |
$198,744 |
D/D |
(2,080) |
3,585 |
|
- |
|
Needham Jeffrey |
Sr. VP Commercial Business Dev |
|
2011-08-31 |
4 |
OE |
$20.50 |
$42,640 |
D/D |
2,080 |
5,665 |
|
- |
|
Arkin Moshe |
Director |
|
2011-08-30 |
4 |
S |
$96.46 |
$16,411,795 |
I/I |
(170,145) |
5,063,122 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2011-08-30 |
4 |
S |
$96.86 |
$347,641 |
D/D |
(3,589) |
0 |
|
- |
|
Hendrickson John T |
EVP Global Operations & Supply |
|
2011-08-30 |
4 |
OE |
$20.50 |
$73,575 |
D/D |
3,589 |
3,589 |
|
- |
|
Lebel Refael |
EVP & GM Perrigo Israel |
|
2011-08-30 |
4 |
OE |
$96.68 |
$402,285 |
D/D |
4,161 |
8,886 |
|
- |
|
Lebel Refael |
EVP & GM Perrigo Israel |
|
2011-08-30 |
4 |
OE |
$20.50 |
$85,301 |
D/D |
4,161 |
13,047 |
|
- |
|
Farrington Thomas |
Senior VP and CIO |
|
2011-08-30 |
4 |
AS |
$94.01 |
$186,303 |
D/D |
(1,956) |
1,903 |
|
- |
|
Farrington Thomas |
Senior VP and CIO |
|
2011-08-30 |
4 |
OE |
$20.50 |
$40,098 |
D/D |
1,956 |
3,859 |
|
- |
|
Kochan Sharon |
Executive VP U.S. Generics |
|
2011-08-30 |
4 |
S |
$95.71 |
$501,903 |
D/D |
(5,216) |
4,126 |
|
- |
|
Kochan Sharon |
Executive VP U.S. Generics |
|
2011-08-30 |
4 |
OE |
$20.50 |
$59,717 |
D/D |
2,913 |
7,039 |
|
- |
|
Stewart Michael Robert |
Sr. VP Global Human Resources |
|
2011-08-30 |
4 |
S |
$95.17 |
$851,880 |
D/D |
(8,946) |
2,532 |
|
- |
|
Stewart Michael Robert |
Sr. VP Global Human Resources |
|
2011-08-30 |
4 |
OE |
$15.47 |
$232,788 |
D/D |
7,946 |
10,478 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-08-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
188 |
206,282 |
|
- |
|
1400 Records found
|
|
Page 17 of 56 |
|
|